1 Day
Source:
مرسال قطر
Sidra Therapeutics launches first SMA gene therapy
Sadera Medical Center introduced the first gene therapy for Spinal Muscular Atrophy, a treatment based on advanced gene therapy techniques. The goal of the therapy is to correct the genetic mutation causing the disease by introducing healthy genes to compensate for the genetic damages that lead to muscle weakness. This achievement represents a significant step in the treatment of Spinal Muscular Atrophy, as it is expected to improve patients' quality of life and reduce their dependence on continuous care. The therapy relies on advanced technologies and requires careful medical monitoring to ensure its success and to assess its impact on patients.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)